Elixir Medical is a medical device company committed to transforming care for patients with heart and vascular disease through innovation. Since 2005, Elixir Medical has advanced interventional cardiology through breakthrough technologies, including: - The DynamX® Coronary Bioadaptor System, a coronary implant uniquely designed not only to restore blood flow but also to allow the artery to uniquely return to its natural physiology, motion, and function while continuing to provide dynamic support. By restoring vessel physiology, the DynamX bioadaptor is designed to significantly reduce cardiac related event rates. - The LithiX™ Hertz Contact Lithotripsy Catheter, a novel intravascular lithotripsy device that uses Hertz Contact Stress to work selectively on calcium within the lesion, breaking and fragmenting the hardened plaque under low balloon inflation pressure. Designed with deliverability, safety and versatility of use in mind, it enables deep, wide calcium fractures regardless of morphology, and optimal stent expansion for effective lesion preparation. At Elixir we believe that only by harnessing the power of transformation can there be real-world impact. We are re-imagining how radical medical technologies will breathe new life into vascular interventions, reshaping it for decades to come. We’re honored to have been featured by Fast Company for our work advancing the next generation of treatment in interventional cardiology. Read the full article here: https://lnkd.in/gMy8nkt8 PMN 2300 Rev A
Looking for a particular Elixir Medical Corporation employee's phone or email?
The Elixir Medical Corporation annual revenue was $18.8 million in 2026.
Motasim Sirhan is the CEO of Elixir Medical Corporation.
79 people are employed at Elixir Medical Corporation.
Elixir Medical Corporation is based in Milpitas, California.
The NAICS codes for Elixir Medical Corporation are [33, 339].
The SIC codes for Elixir Medical Corporation are [384, 38].